These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21299438)

  • 1. Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement.
    Ansaldi F; Durando P; Icardi G
    Expert Opin Biol Ther; 2011 Mar; 11(3):415-27. PubMed ID: 21299438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluzone(®) Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults.
    Ansaldi F; de Florentiis D; Durando P; Icardi G
    Expert Rev Vaccines; 2012 Jan; 11(1):17-25. PubMed ID: 22149703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptance and opinions of Intanza/IDflu intradermal influenza vaccine in the Czech Republic and Turkey.
    Prymula R; Usluer G; Altinel S; Sichova R; Weber F
    Adv Ther; 2012 Jan; 29(1):41-52. PubMed ID: 22228256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intanza(®): a new intradermal vaccine for seasonal influenza.
    Atmar RL; Patel SM; Keitel WA
    Expert Rev Vaccines; 2010 Dec; 9(12):1399-409. PubMed ID: 21105776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
    Holland D; Booy R; De Looze F; Eizenberg P; McDonald J; Karrasch J; McKeirnan M; Salem H; Mills G; Reid J; Weber F; Saville M
    J Infect Dis; 2008 Sep; 198(5):650-8. PubMed ID: 18652550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial.
    Beran J; Ambrozaitis A; Laiskonis A; Mickuviene N; Bacart P; Calozet Y; Demanet E; Heijmans S; Van Belle P; Weber F; Salamand C
    BMC Med; 2009 Apr; 7():13. PubMed ID: 19341446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system.
    Icardi G; Orsi A; Ceravolo A; Ansaldi F
    Hum Vaccin Immunother; 2012 Jan; 8(1):67-75. PubMed ID: 22293531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intanza(®) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses.
    Ansaldi F; Canepa P; Ceravolo A; Valle L; de Florentiis D; Oomen R; Vogel FR; Denis M; Samson SI; Icardi G
    Vaccine; 2012 Apr; 30(18):2908-13. PubMed ID: 22342501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina.
    Eizenberg P; Booy R; Naser N; Mason G; Stamboulian D; Weber F
    Adv Ther; 2011 Aug; 28(8):640-9. PubMed ID: 21751080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly.
    Levin Y; Kochba E; Shukarev G; Rusch S; Herrera-Taracena G; van Damme P
    Vaccine; 2016 Oct; 34(44):5262-5272. PubMed ID: 27667332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain.
    Hung IF; Levin Y; To KK; Chan KH; Zhang AJ; Li P; Li C; Xu T; Wong TY; Yuen KY
    Vaccine; 2012 Oct; 30(45):6427-35. PubMed ID: 22910287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study.
    Arnou R; Icardi G; De Decker M; Ambrozaitis A; Kazek MP; Weber F; Van Damme P
    Vaccine; 2009 Dec; 27(52):7304-12. PubMed ID: 19849996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose sparing with intradermal injection of influenza vaccine.
    Kenney RT; Frech SA; Muenz LR; Villar CP; Glenn GM
    N Engl J Med; 2004 Nov; 351(22):2295-301. PubMed ID: 15525714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine.
    Coleman BL; McGeer AJ; Halperin SA; Langley JM; Shamout Y; Taddio A; Shah V; McNeil SA
    Vaccine; 2012 Sep; 30(44):6287-93. PubMed ID: 22902784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination.
    Morelon E; Pouteil Noble C; Daoud S; Cahen R; Goujon-Henry C; Weber F; Laurent PE; Kaiserlian D; Nicolas JF
    Vaccine; 2010 Oct; 28(42):6885-90. PubMed ID: 20709000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antibody responses after intradermal vaccination against influenza.
    Belshe RB; Newman FK; Cannon J; Duane C; Treanor J; Van Hoecke C; Howe BJ; Dubin G
    N Engl J Med; 2004 Nov; 351(22):2286-94. PubMed ID: 15525713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects.
    Fukase H; Furuie H; Yasuda Y; Komatsu R; Matsushita K; Minami T; Suehiro Y; Yotsuyanagi H; Kusadokoro H; Sawata H; Nakura N; Lattanzi M
    Vaccine; 2012 Jul; 30(33):5030-7. PubMed ID: 22472791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
    Künzi V; Klap JM; Seiberling MK; Herzog C; Hartmann K; Kürsteiner O; Kompier R; Grimaldi R; Goudsmit J
    Vaccine; 2009 Jun; 27(27):3561-7. PubMed ID: 19464535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluzone® Intradermal Quadrivalent Influenza Vaccine.
    Robertson CA; Tsang P; Landolfi VA; Greenberg DP
    Expert Rev Vaccines; 2016 Oct; 15(10):1245-53. PubMed ID: 27457797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults.
    Leroux-Roels I; Vets E; Freese R; Seiberling M; Weber F; Salamand C; Leroux-Roels G
    Vaccine; 2008 Dec; 26(51):6614-9. PubMed ID: 18930093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.